ОбзорГрафикПрофильОсновная статистикаФинансовые показателиНовости
Деривативы
TraderScreen

UCB S.A./  BE0003739530  /

Vienna Global Market
15.11.2024  15:30:29 Изменение -12.25 Объем сделки Бид17:30:04 Предложение17:30:04 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
167.55EUR -6.81% 0
Оборот: -		 -Величина цены спроса: - -Величина цены предложения: - 31.78 млрдEUR 0.81% 92.40
GlobeNewswire 26.08 Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice...
GlobeNewswire 26.08 MDA Kicks Off Muscular Dystrophy Awareness Month in September with ‘30 Days of Strength’ Campaign wi...
GlobeNewswire 15.08 United Community Banks, Inc. Announces Increased Quarterly Cash Dividend and Larger Share Repurchase...
GlobeNewswire 13.08 Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Resul...
GlobeNewswire 26.07 United Community Banks, Inc. Announces Transfer of Listing of Common Stock and Depositary Shares to ...
GlobeNewswire 08.07 Conflicting Views Between Epileptologists and General Neurologists Hinder Adoption of New Refractory...
GlobeNewswire 28.06 United Community Banks, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference ...
GlobeNewswire 04.06 Chair of UC Berkeley Nuclear Engineering Department Joins NANO Nuclear Energy as Lead Developer of ‘...
GlobeNewswire 04.06 ExeVir Bio Announces Exceptional Virus Neutralization Potency of its Variant-proof XVR013m Antibody ...
GlobeNewswire 03.06 7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the...
GlobeNewswire 09.05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 01.05 Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer
GlobeNewswire 30.04 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire 30.04 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire 15.04 London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulpha...
GlobeNewswire 01.04 Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire 25.03 Marathon Digital Holdings Releases Industry-Leading Bitcoin Mining Firmware and Control Board
GlobeNewswire 05.03 Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...
GlobeNewswire 05.03 Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 F...
GlobeNewswire 28.02 Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...
GlobeNewswire 16.02 United Community Banks, Inc. Announces Quarterly Cash Dividends on Preferred Stock
GlobeNewswire 08.02 Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Ca...
GlobeNewswire 22.01 Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilizati...
GlobeNewswire 15.01 ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron...
GlobeNewswire 07.01 Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical ...